Theralink Technologies, Inc.
THER
$0.0001
$0.000.00%
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -298.09% | 113.67% | 152.53% | 76.50% | -374.39% |
| Total Depreciation and Amortization | -9.92% | -1.53% | -3.69% | 7.33% | 6.99% |
| Total Amortization of Deferred Charges | -34.81% | 0.63% | 3.26% | 177.93% | 575.92% |
| Total Other Non-Cash Items | 181.17% | -58.46% | -624.35% | -93.63% | 438.75% |
| Change in Net Operating Assets | -32.32% | 47.99% | 319.71% | -36.62% | -8.79% |
| Cash from Operations | 35.99% | -99.80% | 56.78% | 1.95% | -91.19% |
| Capital Expenditure | -- | -- | -- | 100.00% | 81.57% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 100.00% | 81.57% |
| Total Debt Issued | -- | 395.97% | -29.84% | -68.66% | 104.21% |
| Total Debt Repaid | 95.86% | -1,820.44% | -3.01% | 89.99% | -963.20% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -100.41% | 361.74% | -30.37% | -67.54% | 103.29% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -200.13% | 631.95% | 80.20% | -225.17% | 175.15% |